Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Download
Faster access than browser!
 

Breast cancer and Idoxifene

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Breast cancer and Idoxifene

Breast cancer vs. Idoxifene

Breast cancer is cancer that develops from breast tissue. Idoxifene (INN, USAN, BAN) (former developmental code names CB-7432, SB-223030), also known as pyrrolidino-4-iodotamoxifen, is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group which was under development for the treatment of breast cancer and postmenopausal osteoporosis but was never marketed.

Similarities between Breast cancer and Idoxifene

Breast cancer and Idoxifene have 2 things in common (in Unionpedia): Menopause, Selective estrogen receptor modulator.

Menopause

Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children.

Breast cancer and Menopause · Idoxifene and Menopause · See more »

Selective estrogen receptor modulator

Selective estrogen receptor modulators (SERMs) are a class of drugs that act on the estrogen receptor (ER).

Breast cancer and Selective estrogen receptor modulator · Idoxifene and Selective estrogen receptor modulator · See more »

The list above answers the following questions

Breast cancer and Idoxifene Comparison

Breast cancer has 264 relations, while Idoxifene has 13. As they have in common 2, the Jaccard index is 0.72% = 2 / (264 + 13).

References

This article shows the relationship between Breast cancer and Idoxifene. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »